December 28, 2012，Institute of Economics of the Chinese Academy of Social Sciences、Social Science Literature Publish、Director Zhu Hengpeng's medicine blue book "China Pharmaceutical Market Report (2012)" (hereinafter referred to as & ldquo; Blue Book & RDQUO;)。
Blue Book pointed out，The Chinese pharmaceutical market shows high -speed expansion、Fierce competition、My stake betting appLow Stake Sports Bettingindustry concentration、Disposal affected by policies。Foreign -funded enterprises play an important role in the Chinese pharmaceutical market，Especially in the high -end third -level hospital drug market, occupying a large market share。
stake online sports betting
Blue Book pointed out，2005 ~ 2010，The Stake Sports BettingCompound growth rate of the Chinese pharmaceutical market exceeds 20%。According to the research report of Zhongkang Consultation，2012 retail terminal drug sales scale was 172.6 billion yuan，It can be calculated that the total scale of the Chinese pharmaceutical market in 2012 is 926.1 billion yuan。Blue Book also predict，2013 ～ 2020 Chinese pharmaceutical market growth rate will reach 12%，By 2020，The size of the Chinese pharmaceutical market will reach 2.3 trillion yuan。Population aging、The increase in social security level and the increase in residential income are the fundamental motivation of the pharmaceutical market expansion。
Blue Book pointed out，The market share of domestic pharmaceutical companies is expanding simultaneously with the growth of drug demand。But foreign companies play an important role in the Chinese pharmaceutical market，Especially in the high -end third -level hospital drug market, occupying a large market share。
Take 2011 as an example，The top 10 pharmaceutical companies in the pharmaceutical market share of the third -level hospital are Pfizer Pharmaceutical、Astrikan、Stake Sports Bettingstake betting appSanofi-Anwte、Bayer-Xianling、Roche Pharmaceutical、Shandong Qilu、Novartis Pharmaceutical、Jiangsu Hengrui、GSK and Ferrsonus; the top 10 drug market share in the secondary hospital is Pfizer Pharmaceutical、Sanofi-Anwte、Bayer-Xianling、Yangzijiang Pharmaceutical、Pharmaceutical Group、Astrikan、Novartis Pharmaceutical、Harbin Pharmaceutical Group、Novo and Baiyunshan Pharmaceutical Group。The top 5 pharmaceutical companies in the pharmaceutical market in the third -level hospital are foreign companies，This means that foreign companies have more advantages in high -end three -level hospital drug markets，and gradually penetrate the pharmaceutical market of secondary hospitals; relative to the drug market of the tertiary hospital，Domestic enterprises temporarily maintain a larger development space in the drug market in the secondary hospital。
Two and third -level hospitals become an important part of the market
2、Third -level hospital is the most important part of the Chinese pharmaceutical market。Current，my country II、The growth characteristics of the drug market of third -level hospitals: 2006 ~ 2011，The drug market of the hospital is growing at a high speed，Stake Sports BettingCompound growth rate of drugs in the third -level stake sports betting apphospital reached 22.29%，The compound growth rate of drugs in the secondary hospital reached 20.53%; the growth rate declined year by year，2007 2、The year -on -year growth rate of three -level hospitals exceeds 25%，The growth rate in 2011 is lower than 15%，The growth rate has decreased more than 10 percentage points; the pharmaceutical market of the third -level hospital is stronger than that of the secondary hospital;，2006 ~ 2011，The average growth rate of market size in the central and western regions is 26.64%、27.06%，and only 20.13%in the eastern region; large and medium -sized hospital drug markets grow faster than small hospitals。
In 2011, the proportion of the use of the three -level hospital from large to small is in order: anti -infective drugs for the whole body、Anti -tumor and immune regulator、digestive system and metabolic drugs、Cardiovascular system drugs、Blood and hematopoietic system drugs、Neurological system drugs。
